Seeing Is Believing

Currently out of the existing stock ratings of Matthew Sheerin, 107 are a BUY (47.98%), 116 are a HOLD (52.02%).
Analyst Matthew Sheerin, currently employed at STIFEL, carries an average stock price target met ratio of 91.36% that have a potential upside of 23.65% achieved within 260 days.
Matthew Sheerin’s has documented 425 price targets and ratings displayed on 23 stocks. The coverage is on Technology, Healthcare sectors.
Most recent stock forecast was given on PRVA, Privia Health Group at 10-Apr-2025.
Analyst best performing recommendations are on SONO (SONOS).
The best stock recommendation documented was for SONO (SONOS) at 8/27/2018. The price target of $20 was fulfilled within 1 day with a profit of $1.08 (5.71%) receiving and performance score of 57.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 03-Feb-2023
$148
$-9.03 (-5.75%)
$120
17 days ago
(06-Feb-2026)
16/18 (88.89%)
$-10.6 (-6.68%)
167
Sell Since 03-Feb-2023
$115
$-42.03 (-26.77%)
$98
17 days ago
(06-Feb-2026)
8/10 (80%)
$-43.6 (-27.49%)
312
Sell Since 07-Feb-2025
$110
$-47.03 (-29.95%)
$99
8 months 14 days ago
(09-Jun-2025)
9/9 (100%)
$-13.28 (-10.77%)
322
Buy Since 02-Feb-2022
$135
$-22.03 (-14.03%)
$140
1 years 3 months 22 days ago
(01-Nov-2024)
5/5 (100%)
$13.97 (11.54%)
733
Hold Since 20-Sep-2016
$132
$-25.03 (-15.94%)
$132
1 years 8 months 26 days ago
(28-May-2024)
5/5 (100%)
$1.78 (1.37%)
11
What Year was the first public recommendation made by Matthew Sheerin?